05May 2022
Severe iatrogenic hypoglycaemia modulates the fibroblast growth factor protein response

Severe iatrogenic hypoglycaemia modulates the fibroblast growth factor protein response

There is evidence that fibroblast growth factor (FGF) levels may be implicated in hypoglycaemia, with FGF19 being a potential contributor to insulin‐independent pathways driving postprandial hypoglycaemia following bariatric surgery and basic FGF (FGF2) being elevated following mild hypoglycaemia occurring after the glucose tolerance test. FGF and FGF receptor proteins were determined by Slow Off‐rate Modified Aptamer (SOMA)‐scan plasma protein measurement. Severe transient hypoglycaemia modulated FGF7, 16, 19, 20 and 23 (known to be associated with diabetes), together with FGF18 and 12, not previously reported to be associated with diabetes, but that may be important in the pathophysiology of hypoglycaemia; FGF20 remained low at 24 h. These data suggest that recurrent hypoglycaemia may contribute to the development of complications through changes in FGF proteins.

  • #endo-diabetology

Like

Save

Share